Implementation and patient outcomes of a pediatric COVID-19 monoclonal antibody program.

A tiered allocation process may provide the framework for the stratification and efficient distribution of mAb therapies. Future research must focus on efficacy of these therapies in the pediatric population, standardized therapeutic prioritization, and the optimal timeframe for mAb delivery to prevent progression to severe disease.